GenScript

GenScript

A biotech company founded in 2002 focusing on early drug discovery and development services.

GenScript's portfolio of services include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development. Examples of GenScript services and products are gene synthesis, peptide, protein, antibody and preclinical drug development services.Services are provided to pharmaceutical companies, biotech firms, and research institutions in the United States, Europe, and Japan.

Genscript Biotech Corporation, an investment holding, is a subsidiary of GenScript Corporation.

GenScript’s GenBrick synthesis service provides DNA sequences as building blocks for synthetic biology applications. Their proprietary technology is used for one-step assembly of DNA fragments, rather than constructing from oligos an short DNA segments.

Genscript developed a test for coronavirus based on a qRT-PCR detection assay that measures the amount of an infectious agent in the bloodstream. The test is being offered freely to researchers. Genscript synthesized genes for use as a positive control for detection of 2019-nCoV in vaccine and antibody development. The coronavirus strain has more recently been renamed SARS-CoV-2 with the disease called COVID-19 (coronavirus disease).

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.